Mutua, Michael
89  Ergebnisse:
Personensuche X
?
5

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine ..:

Man-Lik Choi, Edward ; Abu-Baker Mustapher, Ggayi ; Omosa-Manyonyi, Gloria...
https://researchonline.lshtm.ac.uk/id/eprint/4671457/1/1-s2.0-S0264410X23012574-main.pdf.  , 2023
 
?
9

Baseline characteristics of the participants; full analysis..:

Zacchaeus Anywaine (3578855) ; Houreratou Barry (11624604) ; Omu Anzala (10435)...
https://figshare.com/articles/dataset/Baseline_characteristics_of_the_participants_full_analysis_set_sup_b_sup_/18189917.  , 2022
 
?
10

GMCs of EBOV-specific binding antibodies (FANG ELISA, 95% C..:

Zacchaeus Anywaine (3578855) ; Houreratou Barry (11624604) ; Omu Anzala (10435)...
https://figshare.com/articles/figure/GMCs_of_EBOV-specific_binding_antibodies_FANG_ELISA_95_CI_in_adolescents_and_children_/18189914.  , 2022
 
?
11

S1 Study Protocol -:

Zacchaeus Anywaine (3578855) ; Houreratou Barry (11624604) ; Omu Anzala (10435)...
https://figshare.com/articles/journal_contribution/S1_Study_Protocol_-/18189884.  , 2022
 
?
14

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV..:

Anywaine, Zacchaeus ; Barry, Houreratou ; Anzala, Omu...
https://researchonline.lshtm.ac.uk/id/eprint/4664537/1/Safety%20and%20immunogenicity%20of%202-dose%20heterologous%20Ad26.ZEBOV,%20MVA-BN-Filo%20Ebola%20vaccination%20in%20children%20and%20adolescents%20in%20Af.pdf.  , 2022
 
?
15

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV..:

Zacchaeus Anywaine ; Houreratou Barry ; Omu Anzala...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752100/?tool=EBI.  , 2022
 
1-15